- Home
- AKRO vs INSP Comparison
AKRO vs INSP Comparison
Compare AKRO & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- INSP
- Stock Information
- Founded
- AKRO 2017
- INSP 2007
- Country
- AKRO United States
- INSP United States
- Employees
- AKRO N/A
- INSP N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- INSP Medical/Dental Instruments
- Sector
- AKRO Health Care
- INSP Health Care
- Exchange
- AKRO Nasdaq
- INSP Nasdaq
- Market Cap
- AKRO 3.7B
- INSP 3.8B
- IPO Year
- AKRO 2019
- INSP 2018
- Fundamental
- Price
- AKRO $54.00
- INSP $75.17
- Analyst Decision
- AKRO Buy
- INSP Buy
- Analyst Count
- AKRO 10
- INSP 16
- Target Price
- AKRO $73.56
- INSP $147.07
- AVG Volume (30 Days)
- AKRO 4.1M
- INSP 932.8K
- Earning Date
- AKRO 11-07-2025
- INSP 11-03-2025
- Dividend Yield
- AKRO N/A
- INSP N/A
- EPS Growth
- AKRO N/A
- INSP 756.73
- EPS
- AKRO N/A
- INSP 1.74
- Revenue
- AKRO N/A
- INSP $861,312,000.00
- Revenue This Year
- AKRO N/A
- INSP $14.83
- Revenue Next Year
- AKRO N/A
- INSP $14.44
- P/E Ratio
- AKRO N/A
- INSP $44.29
- Revenue Growth
- AKRO N/A
- INSP 22.05
- 52 Week Low
- AKRO $21.34
- INSP $70.77
- 52 Week High
- AKRO $58.40
- INSP $216.01
- Technical
- Relative Strength Index (RSI)
- AKRO 68.71
- INSP 43.50
- Support Level
- AKRO $53.40
- INSP $75.32
- Resistance Level
- AKRO $54.05
- INSP $84.23
- Average True Range (ATR)
- AKRO 0.26
- INSP 2.98
- MACD
- AKRO -0.03
- INSP 0.21
- Stochastic Oscillator
- AKRO 72.46
- INSP 20.61
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.